Zai Lab Limited (ZLAB)
NASDAQ: ZLAB
· Real-Time Price · USD
28.18
-0.44 (-1.54%)
At close: May 14, 2025, 3:59 PM
28.14
-0.16%
After-hours: May 14, 2025, 04:00 PM EDT
Zai Lab Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Nuzyra Revenue | 43.2M | 21.66M | 5.2M | 3K | 16.42M |
| Nuzyra Revenue Growth | +99.48% | +316.46% | +173233.33% | -99.98% | n/a |
| Optune Revenue | 40.48M | 46.97M | 47.32M | 38.9M | 32.14M |
| Optune Revenue Growth | -13.83% | -0.74% | +21.64% | +21.05% | n/a |
| Qinlock Revenue | 28.83M | 19.24M | 14.96M | 11.62M | n/a |
| Qinlock Revenue Growth | +49.82% | +28.64% | +28.72% | n/a | n/a |
| Zejula Revenue | 187.08M | 168.84M | 145.19M | 93.58M | n/a |
| Zejula Revenue Growth | +10.80% | +16.29% | +55.16% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 63.42M | 82.62M | 67.22M | 79.71M | 69.19M | 82.63M | 68.55M | 67.92M | 62.51M | 72.02M | 66.56M | 63.4M | 56.99M | 69.58M | 59M | 54.41M | 35.84M | 40.97M | 27.87M | 23.76M | 18.71M | 23.02M | 17.7M | 14.74M | 14.74M | 10.98M | 4.24M | 3.18M | 3.18M | 4M | 4M | 2.25M | 2.25M | 1.97M | 1.97M | 1.22M | 1.22M |
| Selling, General, and Administrative Revenue Growth | -23.23% | +22.91% | -15.67% | +15.20% | -16.26% | +20.53% | +0.93% | +8.65% | -13.21% | +8.22% | +4.97% | +11.25% | -18.09% | +17.92% | +8.43% | +51.83% | -12.52% | +46.97% | +17.32% | +26.95% | -18.72% | +30.09% | +20.03% | 0.00% | +34.33% | +159.18% | +33.10% | 0.00% | -20.53% | 0.00% | +77.96% | 0.00% | +14.24% | 0.00% | +61.40% | 0.00% | n/a |
| Research and Development Revenue | 60.73M | 52.25M | 65.98M | 61.63M | 54.65M | 81.95M | 58.77M | 76.68M | 48.47M | 66.95M | 99.52M | 66.08M | 53.85M | 172.09M | 55.14M | 142.22M | 203.85M | 62.56M | 58.1M | 68.31M | 33.74M | 32.1M | 51.2M | 29.46M | 29.46M | 55.65M | 29.99M | 17.32M | 17.32M | 9.23M | 9.23M | 10.44M | 10.44M | 11.69M | 11.69M | 4.39M | 4.39M |
| Research and Development Revenue Growth | +16.22% | -20.81% | +7.07% | +12.77% | -33.32% | +39.45% | -23.36% | +58.20% | -27.60% | -32.73% | +50.60% | +22.71% | -68.71% | +212.07% | -61.23% | -30.23% | +225.84% | +7.68% | -14.94% | +102.44% | +5.13% | -37.31% | +73.76% | 0.00% | -47.06% | +85.55% | +73.21% | 0.00% | +87.53% | 0.00% | -11.53% | 0.00% | -10.69% | 0.00% | +166.25% | 0.00% | n/a |